3,024 research outputs found

    Effects of tapentadol on pain, motor symptoms and cognitive functions in Parkinson\u2019s disease

    Get PDF
    Background: Pain is a common and undertreated non-motor symptom in patients with Parkinson\u2019s disease (PD). Opioids have been seldom used in PD because they could worsen cognitive and motor functions. Objective: We aimed to assess efficacy and tolerability of tapentadol in PD patients. Methods: We retrospectively reviewed 21 PD patients treated with tapentadol extended release (ER) for chronic pain. Patients were evaluated before treatment and at 3 and 6 months during treatment for pain intensity (current, 24-hour average, and minimum and worst) with a 0-10 Numerical Rating Scale and the painDETECT questionnaire; for motor symptom severity with the Unified Parkinson\u2019s Disease Rating Scale part III and the Hoehn and Yahr scale; for cognitive functions with MiniMental Status Examination, Corsi\u2019s Block Tapping test, Digit Span, Digit-Symbol Substitution test, FAS test, Rey\u2019s Auditory Verbal Learning test, Trail Making-A and -B, and the 9 Hole-Peg Test; for anxiety and depression with the Hospital Anxiety and Depression Scale; and for the quality of life with the Short Form-12 for Quality of Life. Data were analyzed by one-way ANOVA and paired t-test, and by Friedman\u2019s and Wilcoxon\u2019s test. Statistical significance was taken in all cases as P < 0,05. Results: Pain intensity decreased over the course of treatment. No differences were found in PD symptom severity and dopaminergic drug dosages between pretreatment and treatment evaluations . No decrement in cognitive neuropsychological performances was found and an improvement was observed in Digit Span, Digit-Symbol Substitution test and FAS test. The levels of anxiety, depression and of quality of life improved. Overall tapentadol ER was well tolerated and most patients reported no or mild and short-lived gastroenterological and neurological side effects. Conclusions: These results indicate the potential efficacy and tolerability of medium-high dose of tapentadol ER for the treatment of pain in PD

    Pediatric Oncology: Causes, Treatments, and the Role of Integrated Medicine

    Get PDF
    Cancer is responsible for approximately 10%-12% of childhood deaths, and is second only to accidents as the leading cause of death in individuals over age 14 (Rape & Bush, 1994). There are various forms of cancer that can afflict a child and numerous ways to combat the disease. While it is important to fight the physical aspects of the disease to increase the child\u27s chance of survival, it is also important to deal with the psychological issues that accompany pediatric oncology. Various psychological treatments are available to help a child endure the emotional and physical stresses associated with chemotherapy and other medical procedures. This review paper assesses various studies that evaluate the effects of many psychological treatments aimed at reducing anticipatory nausea/vomiting and children\u27s emotional reactions to future treatments. The studies found that caring attention and emphasis on relaxing techniques to take the children\u27s minds off the pain cancer treatment is causing help the children cope with the effects that the treatment has on them both physically and emotionally
    corecore